Taken together, our study shows that the atherosclerosis-enhancing function of the ubiquitously expressed B2 bradykinin receptor involves a synergistic interplay between enhanced ROS generation, dysfunctional NO activity and AT1 receptor activation. The gene discussed is BDKRB2; the disease is atherosclerosis.